- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | XFRA 5V7: WIEDERAUFNAHME/RESUMPTION | 83 | Xetra Newsboard | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE. THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE: INSTRUMENT... ► Artikel lesen | |
| Fr | Correction: Options at exercise price of $0.10. Ventripoint Engages Torrey Hills Capital to Provide Investor Relations Services | - | TheNewswire | ||
| Fr | Ventripoint Diagnostics Ltd (2): Ventripoint hires Torrey Hills Capital for IR services | 2 | Stockwatch | ||
| VENTRIPOINT DIAGNOSTICS Aktie jetzt für 0€ handeln | |||||
| Fr | Ventripoint Diagnostics Ltd (2): Ventripoint Diagnostics to resume at 6:30 a.m. PT | - | Stockwatch | ||
| Fr | Ventripoint Engages Torrey Hills Capital to Provide Investor Relations Services | 1 | TheNewswire | ||
| Do | Ventripoint Diagnostics Ltd (2): Ventripoint Diagnostics 1,052,942 shares for debt | 2 | Stockwatch | ||
| Do | Ventripoint Diagnostics Ltd (2): Ventripoint Diagnostics to resume at Sept. 25 open | 1 | Stockwatch | ||
| Mi | Ventripoint Diagnostics to resume trading | - | Seeking Alpha | ||
| Mi | Ventripoint To Resume Trading at the Market Opening Friday, September 25, 2020 | - | TheNewswire | ||
| Mi | Ventripoint to resume trading | 1 | Seeking Alpha | ||
| Mi | Ventripoint Diagnostics Ltd (2): Ventripoint to resume trading on TSX-V on Sept. 25 | 1 | Stockwatch | ||
| 19.09. | Ventripoint Diagnostics Ltd (2): Ventripoint $1.22M debenture private placement | 1 | Stockwatch | ||
| 15.09. | Ventripoint Diagnostics Ltd (2): Ventripoint hopes to resume TSX-V trading soon | 1 | Stockwatch | ||
| 15.09. | Ventripoint Provides Corporate Update and Enters Review by TSXV to Resume Trading | 1 | TheNewswire | ||
| 14.09. | Ventripoint Diagnostics Ltd (2): Ventripoint closes final tranche of debenture financing | 1 | Stockwatch | ||
| 14.09. | Ventripoint Announces Closing of Second Tranche of Non-Brokered Secured Convertible Debenture Unit Private Placement | 1 | TheNewswire | ||
| 03.06. | Ventripoint Diagnostics Ltd (2): Ventripoint appoints Hugo CFO | - | Stockwatch | ||
| 03.06. | Ventripoint Announces Appointment of Chief Finance Officer | - | TheNewswire | ||
| 29.05. | Ventripoint Diagnostics Ltd (2): Ventripoint to postpone filing of Q1 2020 financials | - | Stockwatch | ||
| 29.05. | Ventripoint Announces Postponement of First Quarter Filings | - | TheNewswire |
Seite:
1 2 Weiter >>
23 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| RELAY MEDICAL | 0,152 | -0,66 % | Breaking News: Dieser Pennystock kann nun auf "Nasa-Power" setzen! | ||
| PLUS THERAPEUTICS | 2,100 | -2,78 % | Pre-market Movers In Healthcare Sector: DFFN, CVAC, ADTX, ADMA, PSTV... | WASHINGTON (dpa-AFX) - What's moving these stocks in the pre-market hours today?In the Green1. Diffusion Pharmaceuticals Inc. (DFFN) is up more than 8% at $0.99 in pre-market hours Wednesday.... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | 1,936 | +4,76 % | Pre-market Movers In Healthcare Sector: Genetic Technologies, GLPG, NVAX, QTNT, EVFM. | JERUSALEM (dpa-AFX) - What's moving these stocks in the pre-market hours today?In the Green1. Genetic Technologies Limited (GENE) is up over 28% at $4.43 in pre-market trading Friday, following... ► Artikel lesen | |
| TANDEM DIABETES | 91,49 | +0,22 % | Medtronic and Tandem Diabetes Care Enter Into Patent Cross-License Agreement | Medtronic plc (NYSE:MDT) and Tandem Diabetes Care, Inc. (NASDAQ:TNDM) today announced that they have entered into a non-exclusive patent cross-license agreement for certain technologies in the field... ► Artikel lesen | |
| COGNETIVITY NEUROSCIENCES | 0,075 | -15,16 % | Cognetivity Neurosciences presents at virtual Alzheimer's Association International Conference (AAIC) 2020 | ||
| VOLITIONRX | - | - | Cotterford Co. Ltd. Sends Letter to VolitionRX Following Annual Meeting Vote Results Confirming Deep-Seated Discontent Among Shareholders | Majority of the Board Members Failed to Gain Support of Majority of the Outstanding Shares Shareholders Also Rejected Company's Executive Compensation, Stock Incentive Plan and Anti-Shareholder... ► Artikel lesen | |
| INSPIREMD | 0,264 | +5,51 % | InspireMD, Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
| CANCER GENETICS | 3,260 | -1,81 % | CANCER GENETICS, INC - 8-K, Current Report | ||
| BIOMARK DIAGNOSTICS | 0,117 | -4,10 % | Fluidigm Corporation: ImmunoGenomics and Vero Diagnostics Providing COVID-19 Testing with Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR Assay on Biomark HD ... | ||
| PREDICTIVE ONCOLOGY | 0,790 | -4,82 % | Pre-market Movers In Healthcare Sector: POAI, ACET, GNCA, WVE, NAOV. | COPENHAGEN (dpa-AFX) - What's moving these stocks in the pre-market hours today?In the Green1. Predictive Oncology Inc. (POAI) is up over 44% at $1.22 in pre-market trading Wednesday, following... ► Artikel lesen | |
| GI DYNAMICS | 0,001 | 0,00 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 21.07.2020 - 2 | FOLGENDE WERTPAPIERE WERDEN AM 21.07.2020 EX KAPITALMASSNAHME GEHANDELT. THE FOLLOWING SHARES ARE TRADED EX CAPITAL ADJUSTMENT ON 21.07.2020. INSTR EXCH ISIN INSTRUMENT NAME EDP XFRA PTEDP0AM0009 EDP-ENERGIAS... ► Artikel lesen | |
| IMAC HOLDINGS | 0,600 | -4,00 % | IMAC Holdings, Inc. Partners with Safe Balance, LLC to Provide Services that Improve Balance for the Reduction of Fall Risk | ||
| MEDIFOCUS | 0,001 | 0,00 % | Medifocus Inc: Medifocus halted at open | ||
| FRESENIUS | 37,830 | -1,36 % | Credit-Märkte 22.9.: Fresenius, Lorca Telecom Bondco, Iccrea Banca ... | Als einziger Corporate Emittent am EUR Credit Primärmarkt, preiste Fresenius gestern eine Dualtranche Senior Anleihe mit einem Gesamtvolumen iHv. EUR 1 Mrd. (A: EUR 500 Mio., MS+90 BP, 6J; B: EUR 500... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 37,100 | -0,40 % | Seitwärtsstrategien für Siemens Healthineers | Seitwärtsstrategien für Siemens Healthineers Vom Allzeithoch bei knapp 47 Euro (25.5.20) hat sich die Aktie von Siemens Healthineers (DE000SHL1006) mittlerweile gut 20 Prozent entfernt: Aktuell werden... ► Artikel lesen |
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
